Dexcom G7 Compatible Devices | Tandem Diabetes Care

Dexcom G7 continuous glucose monitoring (CGM)* integration with the t:slim X2 insulin pump provides exceptional accuracy¹ for optimized insulin delivery.

Faster Sensor Startup

Spend more time in closed loop with shorter wait times between Dexcom G7 sensor sessions.^†

No Routine Fingersticks

For calibration or mealtime dosing, when the t:slim X2 insulin pump is integrated with Dexcom G7.^‡

10-Day Sensor Wear

Plus an additional 12-hour grace period after the sensor has expired.

Simple Auto-Applicator

A one-touch applicator easily inserts a small sensor with no visible needle.

Update Your Pump Software

Current users with an in-warranty pump can update their software to integrate with Dexcom G7 sensors.^§

* CGM sold separately.

† Faster claim based on two-hour warmup time with the Dexcom G6 sensor vs. 30-minute warmup time with the Dexcom G7 sensor.

‡ If glucose alerts and Dexcom CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

§ Additional feature updates may not be currently available for the t:slim X2 insulin pump with Control-IQ technology and are subject to Health Canada clearance. Additional training may be required to access certain future software updates. Software updates are only available to customers who are in warranty at the time they update their pump. Charges may apply. Future updates for all or some Tandem products may not be developed and may not be offered everywhere. Tandem may discontinue select software and features over time at its discretion.

References

1. Dexcom G7 User Guide, 2024.

2. Nørgaard K, Ranjan AG, Laugesen C, et al. Glucose Monitoring Metrics in Individuals with Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study. Diabetes Care. 2023;dc231137. doi: 10.2337/dc23-1137.

This product may not be right for you. Always read and follow the label.

Important Safety Information

The t:slim X2 insulin pump with Control-IQ technology (the System) consists of the t:slim X2 insulin pump, which contains Control-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the System. When used with a compatible CGM, the System can be used to automatically increase, decrease, and suspend delivery of basal insulin based on CGM sensor readings and predicted glucose values. The System can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The pump and the System are indicated for use in individuals 6 years of age and greater. The pump and the System are intended for single user use. The pump and the System are indicated for use with NovoRapid, Admelog, Trurapi, or Humalog U-100 insulin. The System is intended for the management of Type 1 diabetes.

Warning: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in users who require less than 10 units of insulin per day or who weigh less than 25 kilograms.

The System is not indicated for use in pregnant women, people on dialysis, or critically ill users. Do not use the System if using hydroxyurea.

Users of the pump and the System must: be willing and able to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. If your CGM readings do not match your symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. The t:slim X2 pump must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

The Tandem Source platform is intended for use by individuals with diabetes mellitus who use Tandem Diabetes Care insulin pumps, their caregivers, and their healthcare providers in home and clinical settings. The Tandem Source platform supports diabetes management through the display and analysis of information uploaded from Tandem insulin pumps.

Dexcom Brief Safety Statement

Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.

t:slim X2 Insulin Pump Dexcom G7 Integration

Faster Sensor Startup

No Routine Fingersticks

10-Day Sensor Wear

Simple Auto-Applicator

Control-IQ Technology

Update Your Pump Software

Resources & Support

Connected Care

Disclosures